PATENT CLAIM ANALYSIS

Application Number: 15959626
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "170000"]

Abstract:
A formulation for drug delivery, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of a lipophilic therapeutic agent by formulation with sterols and/or sterol esters, resulting in higher bioavailability of a therapeutic agent administered to a subject in need of such therapeutic agent. The formulation contains a therapeutic agent and a sterol or sterol ester, and can, optionally, further contain a solubilizer and/or an enhancing agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions. Formulations of the disclosure can be constituted to minimize the synthesis of dihydrotestosterone when the therapeutic agent includes testosterone or testosterone esters.

Claim (Index 15):
The oral formulation of  claim 10 , wherein the oral formulation further comprises alpha-tocopherol or alpha-tocopherol acetate.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 91.0
- Lexical Diversity: 1.81159
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13936036', '11911446', '15107492', '14254545', '14649687']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7885677631169533
- 35 USC 102 Novelty (BERT): 0.6228926031265255
- Combined Prediction Score: 0.7720002471179106
- Mean Citation Score: 371.51562
- Max Citation Score: 754.0317
- Similarity Product: 479.31708827855584

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test